236 related articles for article (PubMed ID: 9371241)
1. Synthesis and biological evaluation of 4-(hydroxyalkyl)estradiols and related compounds.
Lovely CJ; Bhat AS; Coughenour HD; Gilbert NE; Brueggemeier RW
J Med Chem; 1997 Nov; 40(23):3756-64. PubMed ID: 9371241
[TBL] [Abstract][Full Text] [Related]
2. 2-(Hydroxyalkyl)estradiols: synthesis and biological evaluation.
Lovely CJ; Gilbert NE; Liberto MM; Sharp DW; Lin YC; Brueggemeier RW
J Med Chem; 1996 Apr; 39(9):1917-23. PubMed ID: 8627615
[TBL] [Abstract][Full Text] [Related]
3. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
4. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
Wiese TE; Polin LA; Palomino E; Brooks SC
J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
[TBL] [Abstract][Full Text] [Related]
5. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to the estrogen receptor of MCF-7 cells in cytosolic extracts and in nuclei of intact cells.
Schütze N; Vollmer G; Wünsche W; Grote A; Feit B; Knuppen R
Exp Clin Endocrinol; 1994; 102(5):399-408. PubMed ID: 7867704
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
7. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
Erber S; Ringshandl R; von Angerer E
Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
[TBL] [Abstract][Full Text] [Related]
8. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
Ashburn SP; Han X; Liehr JG
Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
[TBL] [Abstract][Full Text] [Related]
9. High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity.
Kasiotis KM; Mendorou C; Haroutounian SA; Alexis MN
Steroids; 2006 Mar; 71(3):249-55. PubMed ID: 16360721
[TBL] [Abstract][Full Text] [Related]
10. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
[TBL] [Abstract][Full Text] [Related]
11. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers.
Van Aswegen CH; Purdy RH; Wittliff JL
J Steroid Biochem; 1989 Apr; 32(4):485-92. PubMed ID: 2542691
[TBL] [Abstract][Full Text] [Related]
12. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
13. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
14. Dibenzo[a,g]quinolizin-8-ones: synthesis, estrogen receptor affinities, and cytostatic activity.
von Angerer S; Brandl G; Mannschreck A; Weimar C; Wiegrebe W
Anticancer Drug Des; 1992 Oct; 7(5):351-63. PubMed ID: 1388628
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells.
Tamir S; Eizenberg M; Somjen D; Stern N; Shelach R; Kaye A; Vaya J
Cancer Res; 2000 Oct; 60(20):5704-9. PubMed ID: 11059763
[TBL] [Abstract][Full Text] [Related]
16. Catecholestrogens are MCF-7 cell estrogen receptor agonists.
Schütze N; Vollmer G; Tiemann I; Geiger M; Knuppen R
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):781-9. PubMed ID: 8274412
[TBL] [Abstract][Full Text] [Related]
17. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
18. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics.
Brueggemeier RW; Bhat AS; Lovely CJ; Coughenour HD; Joomprabutra S; Weitzel DH; Vandre DD; Yusuf F; Burak WE
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):145-56. PubMed ID: 11566439
[TBL] [Abstract][Full Text] [Related]
19. Catechol estrogen formation in MCF-7 cell culture and effects of bromoestrogen inhibitors.
Brueggemeier RW; Katlic NE; Palmer CW; Stevens JM
Mol Cell Endocrinol; 1989 Jul; 64(2):161-7. PubMed ID: 2551756
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
